New England Biolabs
Andrew Boslem joined New England Biolabs in 2018 with over 10 years in sales and marketing experience supporting the Life Sciences sector in Australia and New Zealand. After completing a Bachelor of Science (Pathology) with 1st Class Honours from the University of New South Wales, Andrew’s research focused on the mechanisms and effect of DNA Methyltransferases on epigenetic changes involved in cancer development and progression. As General Manager for the NEB Australian and New Zealand Subsidiary, Andrew is responsible for the day-to-day operations of the businesses, striving to provide a world class customer experience while setting leading standards in social and environmental responsibility.
This person is not in any teams
This person is not in any offices
New England Biolabs
New England Biolabs produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing solutions supporting genome editing, synthetic biology and next-generation sequencing.